医疗数据平台
医疗数据平台医疗信息数据服务
MEDICAL LIBRARY

医疗资料库

按文件名称和类型检索 DRG/DIP、制药与医保支付改革相关资料,支持在线预览。

3,308份公开资料
Oculis Holdings_Oculis制药_20250415_R&D Day 2025_P54页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20250415_R&D Day 2025_P54页

54页9.1 MB0次下载
Oculis Holdings_Oculis制药_20250415_R&D Day 2025_P54页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20250415_R&D Day 2025_P54页

54页2.2 MB0次下载
Oculis Holdings_Oculis制药_20250106_OCS-05 Phase 2 Topline Results_P33页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20250106_OCS-05 Phase 2 Topline Results_P33页

33页7.2 MB0次下载
Oculis Holdings_Oculis制药_20250106_OCS-05 Phase 2 Topline Results_P33页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20250106_OCS-05 Phase 2 Topline Results_P33页

33页1.3 MB0次下载
Oculis Holdings_Oculis制药_20240711_R&D Day 2023_P76页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20240711_R&D Day 2023_P76页

76页5.5 MB0次下载
Oculis Holdings_Oculis制药_20240711_R&D Day 2023_P76页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20240711_R&D Day 2023_P76页

76页4.8 MB0次下载
Oculis Holdings_Oculis制药_20240610_RELIEF Phase 2b Topline Readout_P31页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20240610_RELIEF Phase 2b Topline Readout_P31页

31页3.7 MB0次下载
Oculis Holdings_Oculis制药_20240610_RELIEF Phase 2b Topline Readout_P31页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20240610_RELIEF Phase 2b Topline Readout_P31页

31页2.5 MB0次下载
Oculis Holdings_Oculis制药_20240228_R&D Day 2024_P110页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20240228_R&D Day 2024_P110页

110页16.8 MB0次下载
Oculis Holdings_Oculis制药_20240228_R&D Day 2024_P110页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20240228_R&D Day 2024_P110页

110页6.3 MB0次下载
Oculis Holdings_Oculis制药_20231005_Late Breakings DlAMOND Stage 1 Trial Results_P11页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20231005_Late Breakings DlAMOND Stage 1 Trial Results_P11页

11页81.2 KB0次下载
Oculis Holdings_Oculis制药_20231005_Late Breakings DlAMOND Stage 1 Trial Results_P11页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20231005_Late Breakings DlAMOND Stage 1 Trial Results_P11页

11页370.9 KB0次下载
Oculis Holdings_Oculis制药_20230808_OPTIMIZE Trial - Phase 3 Topline Results_P33页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20230808_OPTIMIZE Trial - Phase 3 Topline Results_P33页

33页2.5 MB0次下载
Oculis Holdings_Oculis制药_20230808_OPTIMIZE Trial - Phase 3 Topline Results_P33页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20230808_OPTIMIZE Trial - Phase 3 Topline Results_P33页

33页2.0 MB0次下载
Oculis Holdings_Oculis制药_20230607_Jefferies Healthcare Conference_P39页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20230607_Jefferies Healthcare Conference_P39页

39页4.4 MB0次下载
Oculis Holdings_Oculis制药_20230607_Jefferies Healthcare Conference_P39页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20230607_Jefferies Healthcare Conference_P39页

39页3.1 MB0次下载
Oculis Holdings_Oculis制药_20230522_DIAMOND Trial - DME Phase 3 Stage 1 Results_P30页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20230522_DIAMOND Trial - DME Phase 3 Stage 1 Results_P30页

30页2.1 MB0次下载
Oculis Holdings_Oculis制药_20230522_DIAMOND Trial - DME Phase 3 Stage 1 Results_P30页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20230522_DIAMOND Trial - DME Phase 3 Stage 1 Results_P30页

30页2.2 MB0次下载
Oculis Holdings_Oculis制药_20230413_pipeline and late-stage clinical milestones overview_P39页
PPTX
pharma-ppt

Oculis Holdings_Oculis制药_20230413_pipeline and late-stage clinical milestones overview_P39页

39页5.6 MB0次下载
Oculis Holdings_Oculis制药_20230413_pipeline and late-stage clinical milestones overview_P39页
PDF
pharma-ppt

Oculis Holdings_Oculis制药_20230413_pipeline and late-stage clinical milestones overview_P39页

39页3.5 MB0次下载
Shionogi_盐野义制药_20250728_FY2025 1Q Financial Results_P40页
PPTX
pharma-ppt

Shionogi_盐野义制药_20250728_FY2025 1Q Financial Results_P40页

40页956.4 KB0次下载
Shionogi_盐野义制药_20250728_FY2025 1Q Financial Results_P40页
PDF
pharma-ppt

Shionogi_盐野义制药_20250728_FY2025 1Q Financial Results_P40页

40页1.4 MB0次下载
Shionogi_盐野义制药_20250512_FY2024 Financial Results_P59页
PPTX
pharma-ppt

Shionogi_盐野义制药_20250512_FY2024 Financial Results_P59页

59页3.7 MB0次下载
Shionogi_盐野义制药_20250512_FY2024 Financial Results_P59页
PDF
pharma-ppt

Shionogi_盐野义制药_20250512_FY2024 Financial Results_P59页

59页4.2 MB0次下载